Estimating the direct cost of Type 2 diabetes in Greece: The effects of blood glucose regulation on patient cost

Diabetic Medicine

Volumn 27, Issue 6, 2010, Pages 679-684

  Athanasakis, K ^a   Ollandezos, M ^a   Angeli, A ^b   Gregoriou, A ^a   Geitona, M ^b   Kyriopoulos, J ^a  

^a NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Blood glucose regulation; Cost; Cost analysis; Type 2 diabetes mellitus

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DRUG COST; GLYCEMIC CONTROL; GREECE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION COST; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS;

COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; GREECE; HEALTH CARE COSTS; HUMANS; HYPOGLYCEMIC AGENTS; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 77952714026     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03004.x     Document Type: Article

References (25)

1. World Health Organization (2005). Preventing Chronic Diseases: a Vital Investment.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998 21 : 1414 1431.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for 2000 and projections for 2030. Diabetes Care 2004 27 : 1047 1053.
4. Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C. The epidemiology of Type-2 diabetes mellitus in Greek adults: the ATTICA study. Diabet Med 2005 22 : 1581 1588.
5. Melidonis A, Tournis S, Kompoti MG, Lantzas IL, Rousou VR, Iraklianou SL et al. Increased prevalence of diabetes mellitus in a rural Greek population. Rural Remote Health 2006 6 : 534.
6. Panagiotakos DB, Zeimbekis A, Boutziouka V, Economou M, Kourlaba G, Toutouzas P et al. Long-term fish intake is associated with better lipid profile, arterial blood pressure, and blood glucose levels in elderly people from Mediterranean islands (MEDIS epidemiological study). Med Sci Monit 2007 13 : 307 312.
7. World Health Organization (2004). Global Burden of Disease (GBD) estimates Death and DALY estimates for 2002 by cause for WHO Member States. Available at http://www.who.int/healthinfo/global-burden-disease/en/index.html Last accesssed 09 November 2009.
8. Tountas I. Health of the Greek Population. Centre of Health Services Research, Laboratory of Hygiene and Epidemiology, Medical School, University of Athens, 2007.
9. National Statistical Service of Greece (2006). Physicians by speciality and dentists by geographic region and prefecture. Available at http://www.statistics.gr/gr-tables/S801-SHE-6-TB-AN-06-1-Y-BI.pdf Last accessed 12 October 2009.
10. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003 26 : 917 932.
11. American Diabetes Association. Economic costs of Diabetes in the US in 2007. Diabetes Care 2008 31 : 1 20.
12. Jönsson B, CODE-2 Advisory Board. Revealing the cost of Type II diabetes in Europe. Diabetologia 2002 45 : S5 S12.
13. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 2008 30 : S4 S41.
14. Ministry of Development, General Secretariat of Commerce. 2007 2nd price bulletin. Available at http://www.gge.gr/37/sub.asp?2378 Last accessed 03 September 2009.
15. Organization for Economic Cooperation and Development. OECD Health data 09 CD ROM.
16. Oliva J, Molina B, Lobo F, Monereo S. Direct health care costs of diabetic patients in Spain. Diabetes Care 2004 27 : 2616 2621.
17. Wiréhn AB, Andersson A, Ostgren CJ, Carstensen J. Age-specific direct healthcare costs attributable to diabetes in a Swedish population: a register-based analysis. Diabet Med 2008 25 : 732 737.
18. Ringborg A, Martinell M, Stålhammar J, Yin DD, Lindgren P. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data. Int J Clin Pract 2008 62 : 708 716.
19. Baxter H, Bottomley J, Burns E, Harvey J, Kernohan E, Lawlor D et al. CODE 2-UK The annual cost of care for people with type II diabetes in Great Britain. Diabet Med 2000 17 (Suppl 1 13 (abstract 42).
20. Gilmer TP, O'Connor PJ, Manning W, Rush WA. The cost to health plans of poor glycemic control. Diabetes Care 1997 20 : 1847 1853.
21. Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 2001 24 : 51 55.
22. Liatis S, Thomakos P, Papaoikonomou S, Papazafeiropoulou A, Giannakopoulos N, Karagiaouri E et al. Trends in the management of type 2 diabetes and its prescription drug costs in Greece (1998 & 2006). Exp Clin Endocrinol Diabet 2009 117 : 505 510.
23. Boba M, Yfanti G, Souliotis K, Tountas J, Diamantopoulos E. Epidemiological approach and economic impact for patients with a diabetic foot. Iatriki 2009 95 : 19 26 in Greek A, Sawyer W, Hopkinson P. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value in Health 2001 4 : 392 400.
24. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001 414 : 782 787.
25. Katsilambros N, Aliferis K, Darviri C, Tsapogas P, Alexiou Z, Tritos N et al. Evidence for an increase in the prevalence of known diabetes in a sample of an urban population in Greece. Diabet Med 1993 10 : 87 90.